Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and C…
$1.47+5.00%
报价 2026-11-06
市值
$1.5M
EV
$4.5M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -96.3%
$1.40$40.20
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| NXLNexalin Technology, Inc. | $1.5M | +5.0% | +50.0% | -148.4% | – | – | – | |
| NRXSNeurAxis, Inc. | $78.4M | +2.1% | +174.3% | 85.6% | – | – | – | |
| HBIOHarvard Bioscience, Inc. | $38.1M | -1.2% | +3.1% | 53% | – | 11.2x | 7.4x | |
| SCYXSCYNEXIS, Inc. | $22M | +6.1% | -87.9% | 100% | – | – | – | |
| ENLVEnlivex Therapeutics Ltd. | $21.4M | -8.6% | – | 0% | 0.0x | – | – | |
| RVPRetractable Technologies, Inc. | $16.9M | -0.1% | – | – | – | – | – | |
| MODDModular Medical, Inc. | $10.8M | +3.9% | +996.9% | 0% | – | – | – | |
| CLGNCollPlant Biotechnologies Ltd. | $7.5M | +0.8% | – | -521.7% | – | – | – | |
| XCURExicure, Inc. | $6.2M | +6.7% | – | 0% | – | – | – | |
| 同行中位数 | – | – | +88.7% | 0% | 0.0x | 11.2x | 7.4x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。